// App-Quantinova.ai

OP0231 : COMPARATIVE EFFECTIVENESS OF JAK-INHIBITORS, TNF-INHIBITORS, ABATACEPT AND IL-6 INHIBITORS IN AN INTERNATIONAL COLLABORATION OF REGISTERS OF RHEUMATOID ARTHRITIS PATIENTS (THE “JAK-POT” STUDY)

Researchers

Presenter

  • K. Lauper

Principal Investigators

  • S. A. Bergstra

  • D. Choquette

  • C. Codreanu

  • D. De Cock

  • L. Dreyer

  • O. Elkayam

  • K. Hyrich

  • F. Iannone

  • N. Inanc

  • E. Kristianslund

  • T. K. Kvien

  • B. Leeb

  • G. Lukina

  • D. Nordstrm

  • K. Pavelka

  • M. Pombo-Suarez

  • Z. Rotar

  • M. J. Santos

  • A. Strangfeld

  • D. Courvoisier

  • A. Finckh

Medical Centers

  • HUG, Geneva, Switzerland

  • LUMC, Radiology, Leiden, Netherlands

  • Institut de Recherche en Rhumatologie de Montreal, Montreal, Canada

  • Center of Rheumatic Diseases, Rheumatology, Bucharest, Romania

  • Katholieke Universiteit Leuven, Skeletal Biology and Engineering Research Centre, Leuven, Belgium

  • Aalborg Universitets Hospital, Aalborg, Denmark

  • Tel aviv University, pschology, Tel Aviv, Israel

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, M13 9PT, United Kingdom

  • University Hospital of Bari, GISEA, Rheumatology, Bari, Italy

  • Marmara University, Medical Oncology, Istanbul, Turkey

  • Diakonhjemmet Hospital, Rheumatology Unit, Oslo, Norway

  • State Hospital Stockerau, Rheumatology, Stockerau, Austria

  • VA Nasonova Institute of Rheumatology, Moscow, Russian Federation, Moscow, Russia

  • Helsinki University, ROB-FIN, Helsinki, Finland

  • Institute of Rheumatology, Prague, Czech Republic

  • Hospital Clinico Universitario, Santiago De Compostela, Spain

  • biorx.si, Rheumatology, Ljubljana, Slovenia

  • Faculdade de Medicina, Reuma.pt, Lisboa, Portugal

  • DRFZ, Programme Area Epidemiology, Berlin, Germany

Locations

  • Switzerland

  • Netherlands

  • Canada

  • Romania

  • Belgium

  • Denmark

  • Israel

  • United Kingdom

  • Italy

  • Turkey

  • Norway

  • Austria

  • Russia

  • Finland

  • Czech Republic

  • Spain

  • Slovenia

  • Portugal

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Interleukin 6

Drug/Treatment

  • Abatacept

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved